In this issue:
PAndexanet efficacious for FXa inhibitor-associated ICH but risks stroke
LASTE: benefits to thrombectomy in large-core acute ischemic strokes
Could rADAMTS13 be a novel therapeutic for congenital TTP?
First clinical use of rADAMTS13 for immune TTP a success
INSPIRES: dual antiplatelet therapy beneficial after acute stroke
ULTIMATE-DAPT supports ticagrelor monotherapy one month post ACS PCI
Novel tool identifies patients with ET at risk of progression
Ultra-early tranexamic acid does not stop haematoma growth after ICH
VTE risk with double heterozygous FVL+PTGM genotype
High risk of VTE in patients with VEXAS syndrome
Please login below to download this issue (PDF)